Long-term outcome of catheter ablation in atrial fibrillation patients with coexistent metabolic syndrome and obstructive sleep apnea: Impact of repeat procedures versus lifestyle changes

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 9, 2014, Pages 930-938

  Mohanty, Sanghamitra ^a,b   Mohanty, Prasant ^a   Di Biase, Luigi ^a,c,d,e   Bai, Rong ^a,f   Trivedi, Chintan ^a   Santangeli, Pasquale ^a,d   Santoro, Francesco ^d   Hongo, Richard ^g   Hao, Steven ^g   Beheiry, Salwa ^g   Burkhardt, David ^a   Gallinghouse, Joseph G ^a   Horton, Rodney ^a   Sanchez, Javier E ^a   Bailey, Shane ^a   Hranitzky, Patrick M ^a   Zagrodzky, Jason ^a   Natale, Andrea ^a,c,g,h,i,j  

^a Texas Cardiac Arrhythmia Institute St David's Medical Center ^*  (United States)

^b The University of Texas at Austin   (United States)

^c The University of Texas at Austin   (United States)

^d UNIVERSITY OF FOGGIA   (Italy)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ SCRIPPS CLINIC   (United States)

^j CASE WESTERN RESERVE UNIVERSITY   (United States)

more..

Author keywords

Atrial fibrillation; Catheter ablation; Lifestyle modifications; Metabolic syndrome; Obstructive sleep apnea; Recurrence

Indexed keywords

ANTIARRHYTHMIC AGENT; ISOPRENALINE; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVERSION; CATHETER ABLATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PAROXYSMAL HEART ATRIUM FIBRILLATION; PREVALENCE; PROSPECTIVE STUDY; RECURRENT DISEASE; REPEAT PROCEDURE; SLEEP DISORDERED BREATHING; TREATMENT OUTCOME; ATRIAL FIBRILLATION; COMPLICATION; EVALUATION STUDY; LIFESTYLE; REOPERATION; TIME;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REOPERATION; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908131283     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12468     Document Type: Article

References (39)

1. Mohanty S, Di Biase L, Bai R, Santangeli P, Pump A, Horton R, Sanchez JE, Natale A: Quality of life and patient-centered outcomes following atrial fibrillation ablation: Short and long-term perspectives to improving care. Expert Rev Cardiovasc Ther 2012;10:889-900.
2. Tanner RM, Baber U, Carson AP, Voeks J, Brown TM, Soliman EZ, Howard VJ, Muntner P: Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol 2011;108:227-232.
3. Fusetti M, Fioretti AB, Valenti M, Masedu F, Lauriello M, Pagliarella M: Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital 2012;32:320-325.
4. Patel D, Mohanty P, Di Biase L, Shaheen M, Lewis WR, Quan K, Cummings JE, Wang P, Al-Ahmad A, Venkatraman P, Nashawati E, Lakkireddy D, Schweikert R, Horton R, Sanchez J, Gallinghouse J, Hao S, Beheiry S, Cardinal DS, Zagrodzky J, Canby R, Bailey S, Burkhardt JD, Natale A: Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: The impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol 2010;3: 445-451.
5. Calvin AD, Albuquerque FN, Lopez-Jimenez F, Somers VK: Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord 2009;7:271-278.
6. Mohanty S, Mohanty P, Di Biase L, Bai R, Pump A, Santangeli P, Burkhardt D, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Zagrodzky J, Natale A: Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol 2012;59:1295-1301.
7. Sarinc Ulasli S, Gunay E,Koyuncu T,AkarO,Halici B, Ulu S,UnluM: Predictive value of Berlin questionnaire and Epworth Sleepiness Scale for obstructive sleep apnea in a sleep clinic population. Clin Respir J 2013. doi: 10.1111/crj.12070.
8. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P,Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio. Circulation 2010;121:2550-2556.
9. Santangeli P, Di Biase L, Sanchez J, Horton R, Natale A: Atrial fibrillation ablation without interruption of anticoagulation. Cardiol Res Pract 2011;2011:837-841.
10. Themistoclakis S, Corrado A, Marchlinski FE, Jais P, Zado E, Rossillo A, Di Biase L, Schweikert RA, Saliba WI, Horton R, Mohanty P, Patel D, Burkhardt DJ,Wazni OM, Bonso A, Callans DJ, Haissaguerre M, Raviele A, Natale A: The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010;55:735-743.
11. Durrleman S, Simon S. Flexible regression models with cubic splines. Stat Med 1989;8:551-561.
12. Harrell FE Jr: DASPLINE Macro. http://biostat.mc.vanderbilt.edu/ twiki/pub/Main/SasMacros/survrisk.txt (Accessed February 24, 2014).
13. Royston P, Sauerbrei W: A new measure of prognostic separation in survival data. Stat Med 2004;23:723-748.
14. Rudloff U, Jacks LM, Goldberg JI,Wynveen CA, Brogi E, Patil S, Van Zee J:Nomogram for predicting the risk of local recurrence after breastconserving surgery for ductal carcinoma in situ. JCO 2010;28:3762-3769.
15. Umetani K, Kodama Y, Nakamura T, Mende A, Kitta Y, Kawabata K, Obata JE, Takano H, Kugiyama K: High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Circ J 2007;71:252-255.
16. Azevedo A, Bettencourt P, Almeida PB, Santos AC, Abreu- Lima C, Hense HW, Barros H: Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities-cross-sectional study of the general population. BMC Cardiovasc Disord 2007;7:17:1-9.
17. Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C: Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol 2011;58:1343-1350.
18. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, Ma CS: Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2009;73:438-443.
19. Cai L, Yin Y, Ling Z, Su L, Liu Z,Wu J, Du H, Lan X, Fan J, ChenW, Xu Y, Zhou P, Zhu J, Zrenner B: Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2013;164:82-87.
20. Bhargava M, Di Biase L, Mohanty P, Prasad S, Martin DO, Williams- Andrews M, Wazni OM, Burkhardt JD, Cummings JE, Khaykin Y, Verma A, Hao S, Beheiry S, Hongo R, Rossillo A, Raviele A, Bonso A, Themistoclakis S, Stewart K, Saliba WI, Schweikert RA, Natale A: Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: Results from a multicenter study. Heart Rhythm 2009;6:1403-1412.
21. Matiello M, Nadal M, Tamborero D, Berruezo A, Montserrat J, Embid C, Rios J, Villacastín J, Brugada J, Mont L: Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 2010;12:1084-1089.
22. Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X: Metaanalysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011;108:47-51.
23. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P: Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation. Heart Rhythm 2012;9:321-327.
24. Camen G, Clarenbach CF, Stöwhas AC, Rossi VA, Sievi NA, Stradling JR, Kohler M: The effects of simulated obstructive apnea and hypopnea on arrhythmic potential in healthy subjects. Eur J Appl Physiol 2013;113:489-496.
25. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE: Syndrome Z: The interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53(Suppl 3):S25-S28.
26. Michalakis K, Mintziori G, Kaprara A, Tarlatzis BC, Goulis DG: The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review. Metabolism 2013;62:457-478.
27. Roberts CK, Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712.
28. Holvoet P: Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 2008;70:193-219.
29. Kourliouros A, Camm AJ: Does inflammation influence atrial fibrillation recurrence following catheter ablation? Europace 2009;11:135-137.
30. Spach MS, Dolber PC: Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986;58:356-371.
31. Lin YK, Lin FZ, Chen YC, Cheng CC, Lin CI, Chen YJ, Chen SA: Oxidative stress on pulmonary vein and left atrium arrhythmogenesis. Circ J 2010;74:1547-1556.
32. Goodson BL, Wung SF, Archbold KH: Obstructive sleep apnea hypopnea syndrome and metabolic syndrome: A synergistic cardiovascular risk factor. J Am Acad Nurse Pract 2012;24:695-703.
33. Vyssoulis G, Karpanou E, Adamopoulos D, Kyvelou SM, Tzamou V, Michaelidis A, Stefanadis C: Metabolic syndrome and atrial fibrillation in patients with essential hypertension. Nutr Metab Cardiovasc Dis 2013;23:109-114.
34. Bo S, Ciccone G, Baldi C, Benini L, Dusio F, Forastiere G, Lucia C, Nuti C, Durazzo M, Cassader M, Gentile L, Pagano G: Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med 2007;22:1695-1703.
35. Tuomilehto H, Gylling H, Peltonen M, Martikainen T, Sahlman J, Kokkarinen J, Randell J, Tukiainen H, Vanninen E, Partinen M, Tuomilehto J, Uusitupa M, Seppä J; Kuopio Sleep Apnea Group: Sustained improvement in mild obstructive sleep apnea after a dietand physical activity-based lifestyle intervention: Postinterventional follow-up. Am J Clin Nutr 2010;92:688-696.
36. Pritchett A, Foreyt J, Mann D: Treatment of the metabolic syndrome: The impact of lifestyle modification. Curr Atheroscler Rep 2005;7:95-102.
37. Mozaffarian D, Furberg C, Psaty B, Siscovick D: Physical activity and incidence of atrial fibrillation in older adults: The cardiovascular health study. Circulation 2008;118:800-807.
38. Lowres N, Neubeck L, Freedman S, Briffa T, Bauman A, Redfern J: Lifestyle risk reduction interventions in atrial fibrillation: A systematic review. Eur J Prev Cardiol 2012;19 1091-1100.
39. Aoki J, Uchino K: Treatment of risk factors to prevent stroke. Neurotherapeutics 2011;8:463-474.